FDA Updates Class I Recall for Omnipod 5 Insulin Pumps Due to Under-Delivery Risk
The U.S. Food and Drug Administration has issued an updated Class I recall for specific lots of Insulet Omnipod 5 Pods. The recall is due to a potential defect in the internal tubing that could lead to insulin leakage and insufficient delivery. This issue poses a serious health risk, potentially causing dangerously high blood glucose levels or life-threatening diabetic ketoacidosis.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.